A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229)

Clin Breast Cancer. 2006 Jun;7(2):176-9. doi: 10.3816/CBC.2006.n.032.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cancer Vaccines / administration & dosage
  • Clinical Trials, Phase II as Topic
  • Docetaxel
  • Female
  • Humans
  • Neoplasm Metastasis
  • Poxviridae / immunology
  • Randomized Controlled Trials as Topic
  • Research Design
  • Taxoids / administration & dosage

Substances

  • Antineoplastic Agents, Phytogenic
  • Cancer Vaccines
  • Taxoids
  • Docetaxel